Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer

Figure 3

Correlation of the four pyroptosis-related lncRNA signatures with clinical features. (a) Univariate Cox regression analysis and (b) multivariate Cox regression analysis were applied to inspect whether the pyroptosis-related lncRNA prognostic model was independent of age, sex, and stage. (c) The nomogram included sex, age, risk score, and stage for predicting the 1-year, 3-year, and 5-year survival rates of bladder cancer patients.

(a)

(b)

(c)